Pure Biologics S.A. (WSE:PUR)
Poland · Delayed Price · Currency is PLN 4.300
+0.014 (0.33%)
Jan 7, 2026, 5:00 PM CET
Pure Biologics Market Cap
Pure Biologics has a market cap or net worth of 34.99 million as of January 7, 2026. Its market cap has decreased by -31.16% in one year.
Market Cap
34.99M
Enterprise Value
49.85M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
4.30
Market Cap Chart
Since December 11, 2018, Pure Biologics's market cap has increased from 26.85M to 34.99M, an increase of 30.32%. That is a compound annual growth rate of 3.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 5, 2026 | 34.99M | 20.33% |
| Dec 30, 2025 | 29.08M | -54.90% |
| Dec 30, 2024 | 64.47M | 53.27% |
| Dec 29, 2023 | 42.06M | -18.86% |
| Dec 30, 2022 | 51.84M | -70.44% |
| Dec 30, 2021 | 175.36M | -4.91% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 11, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Diagnostyka | 5.84B |
| NEUCA | 3.73B |
| Synektik Spólka Akcyjna | 2.44B |
| Voxel | 1.35B |
| Celon Pharma | 1.12B |
| Selvita | 805.81M |
| Ryvu Therapeutics | 635.80M |
| Centrum Medyczne ENEL-MED | 509.05M |